Physician profile
Fia Yi
NPI 1255542494
$31,750.52
in general payments reported to CMS, 2019-2025
29 companies · $4,512 in 2025
The $4,512 reported for 2025 was more than what 88% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,236 · 2020: $5,895 · 2021: $17K · 2022: $381 · 2023: $405 · 2024: $1,596 · 2025: $4,512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Food and Beverage: $1,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Food and Beverage | $1,513.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $29,487.23 | 2019-2025 | Da Vinci Surgical System |
| Applied Medical Resources Corporation | $1,000.00 | 2024 | |
| Medtronic, INC. | $340.50 | 2022-2025 | Interstim, Signia |
| Conmed Corporation | $114.88 | 2025 | Airseal |
| Merck Sharp & Dohme LLC | $100.41 | 2023-2025 | Keytruda, Welireg |
| Janssen Biotech, INC. | $89.47 | 2023-2025 | Talvey, Darzalex, Tecvayli |
| Stemline Therapeutics INC. | $87.43 | 2023-2025 | Orserdu |
| Medtronic USA, INC. | $62.06 | 2019-2020 | |
| Ethicon US, LLC | $51.67 | 2024-2025 | Echelon Circular, Echelon Flex, Prolene |
| Daiichi Sankyo INC. | $38.85 | 2024 | Enhertu |
| Glaxosmithkline, LLC. | $32.85 | 2023-2025 | Jemperli, Zejula |
| Smith+Nephew, INC. | $32.53 | 2023-2025 | Stravix, Grafix Pl, Grafix |
| Ipsen Biopharmaceuticals, INC | $28.22 | 2025 | Onivyde |
| Dendreon Pharmaceuticals LLC | $24.01 | 2023 | Provenge |
| Coloplast Corp | $23.99 | 2023 | Sensura Mio |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $21.78 | 2023 | Tivdak |
| Novartis Pharmaceuticals Corporation | $21.43 | 2024 | |
| Aveo Pharmaceuticals, INC. | $20.24 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $18.81 | 2024 | Tagrisso |
| Bayer Healthcare Pharmaceuticals INC. | $18.45 | 2023 | |
| Exelixis INC. | $17.55 | 2024 | Cabometyx |
| Incyte Corporation | $17.11 | 2024 | Monjuvi |
| Genmab U.S., INC. | $15.51 | 2023 | Epkinly |
| Adc Therapeutics America, INC. | $15.18 | 2024 | |
| Amgen INC. | $15.03 | 2023 | Lumakras |
| Emd Serono, INC. | $14.36 | 2025 | |
| Mimedx Group, INC. | $14.18 | 2025 | |
| Morphosys, US INC. | $13.45 | 2023 | Monjuvi |
| Blueprint Medicines Corporation | $13.34 | 2024 | Ayvakit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fia Yi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.